Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers
Authors:
- Sean C. DowdySDSean C. Dowdy
- Ailing XueAXAiling Xue
- Jiang ShujuanJSJiang Shujuan
- Norman L. EberhardtNENorman L. Eberhardt
- Karl C. PodratzKPKarl C. Podratz
- Shi-Wen JiangSJShi-Wen Jiang
- 1 March 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 96 (3) , 601-609
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The rise and fall of genomic methylation in cancerLeukemia, 2003
- Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer.Endocrine-Related Cancer, 2003
- Nuclear localization of the metastasis‐related protein S100A4 correlates with tumour stage in colorectal cancerThe Journal of Pathology, 2003
- Co‐operation and communication between the human maintenance and de novo DNA (cytosine‐5) methyltransferasesThe EMBO Journal, 2002
- The impact of chromatin in human cancer: linking DNA methylation to gene silencingCarcinogenesis, 2002
- The fundamental role of epigenetic events in cancerNature Reviews Genetics, 2002
- Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesisCancer, 2002
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumoursThe Journal of Pathology, 2001
- ?-Catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumoursInternational Journal of Cancer, 1999